Theoretical study of mexiletine and its interaction with cationic and anionic receptor sites

Farmaco

Volumn 54, Issue 10, 1999, Pages 653-659

  Remko, Milan ^a   Smieško, Martin ^a   Beňová, Adriána ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Antiarrhythmic receptor interaction; Mexiletine; Theoretical calculations

Indexed keywords

AMINE; ANION; CATION; MEMBRANE PROTEIN; MEXILETINE;

ARTICLE; BINDING SITE; CALCULATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; GEOMETRY; HYDROGEN BOND; MOLECULAR MODEL; PROTON TRANSPORT; TECHNIQUE;

ANTI-ARRHYTHMIA AGENTS; BINDING SITES; MEXILETINE; MODELS, MOLECULAR; RECEPTORS, DRUG; STEREOISOMERISM;

EID: 0344199931     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00074-9     Document Type: Article

References (32)

1. Somberg J. Antiarrhythmic drug therapy. Cardiology. 72:1985;329-348.
2. R.E. Thomas, in: M.E. Wolff (Ed.), Burger's Medicinal Chemistry and Drug Discovery, Wiley, New York, 1996 (Chapter 28).
3. Nattel S. Antiarrhythmic drug classifications. A critical appraisal of their history, present status and clinical relevance. Drugs. 41:1991;672-701.
4. Kecskemeti V. Molecular action of class I antiarrhythmic drugs and clinical implications. Pharmacol. Res. 24:1991;131-142.
5. Capucci A., Aschieri D., Villani G.Q. Clinical pharmacology of antiarrhythmic drugs. Drugs Aging. 13:1998;51-70.
6. Hille B. Ionic Channels of Excitable Membranes. second ed. 1992;Sinauer, Sunderland, MA.
7. Grant A.O., Starmer C.F., Strauss H.C. Antiarrhythmic drug action: blockade of the inward sodium current. Circ. Res. 55:1984;427-439.
8. + channel subtypes. Biophys. J. 70:1996;1700-1708.
9. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 69:1977;497-515.
10. Grant A.O, Wendt D.J. Block and modulation of cardiac sodium channels by antiarrhythmic drugs, neurotransmitters and hormones. Trends Pharmacol. Sci. 13:1992;352-358.
11. Remko M., Scheiner S. Ab initio investigation of interactions between models of membrane-active compounds and polar groups of membranes: complexes involving amine, ether, amide, phosphate, and carboxylate. J. Pharm. Sci. 80:1991;328-332.
12. Remko M., Rode B.M. Effects of external ions on the energetics of proton transfer in hydrogen bonded systems modelling a membrane-active drug-receptor interaction. J. Chem. Soc., Faraday Trans. 89:1993;1321-1326.
13. Remko M., Scheiner S., Rode B.M. Molecular modelling of the antiarrhythmic-receptor interaction. J. Mol. Struct.: Theochem. 307:1994;35-46.
14. - complexes. J. Mol. Struct.: Theochem. 343:1995;141-147.
15. M. Remko, B.M. Rode, Cation binding effect on hydrogen bonding in the complexes of lidocaine, tocainide and mexiletine with the acetate, J. Mol. Struct.: Theochem. (1999) in press.
16. Remko M. The interaction of antiarrhythmics with an anionic receptor site. IDrugs. 2:1999;243-246.
17. HYPERCHEM, version 5.02, Hypercube Inc., 1115 NW 4th Street, Gainesville, FL 32601-4256, USA, 1998.
18. Baricic P., Mackov M. MOLGEN: personal computer-based modeling system. J. Mol. Graph. 13:1995;184-189.
19. CHEM-X, Chemical Design Ltd., Chipping Norton, OX7 5SR, UK, 1998.
20. Binkley J.S., Pople J.A., Hehre W.J. Self-consistent molecular orbital methods 21. Small split-valence basis sets for first-row elements. J. Am. Chem. Soc. 102:1980;939-947.
21. Sivý J., Kettmann V., Frešová E. Structure of 1-(2,6-dimethylphenoxy)-2-propanamine hydrochloride. Acta Crystallogr., Sect. C. 47:1991;2695-2696.
22. Remko M., Liedl K.R., Rode B.M. Theoretical study of the local anaesthetic-receptor interaction. Chem. Papers. 51:1997;234-241.
23. Boys S.F., Bernardi F. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors. Mol. Phys. 19:1970;553-566.
24. GAUSSIAN-98, Revision A.6, M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, V.G. Zakrzewski, J.A. Montgomery Jr., R.E. Stratmann, J.C. Burant, S. Dapprich, J.M. Millam, A.D. Daniels, K.N. Kudin, M.C. Strain, O. Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, S. Clifford, J. Ochterski, G.A. Petersson, P.Y. Ayala, Q. Cui, K. Morokuma, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J. Cioslowski, J.V. Ortiz, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, C. Gonzalez, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, J.L. Andres, M. Head-Gordon, E.S. Replogle, J.A. Pople, Gaussian, Inc., Pittsburgh, PA, 1998.
25. Wei X., Loi Ch.M., Jarvi E.J., Vestal R.E. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity. Drug Metab. Dispos. 23:1995;1335-1338.
26. Deluca A., Natuzzi F., Lentini G., Franchini C., Tortorella V., Camerino D.C. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers. Naunyn Schmiedebergs Arch. Pharm. 352:1995;653-661.
27. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107:1985;3902-3909.
28. Voigt W., Mannhold R., Limberg J., Blaschke G. Interactions of antiarrhythmics with artificial phospholipid membranes. J. Pharm. Sci. 77:1988;1018-1020.
29. Catterall W.A. Structure and function of voltage-sensitive ion channels. Science. 242:1988;50-61.
30. Wong M.W., Frisch M.J., Wiberg K.B. Solvent effects. 1. The mediation of electrostatic effects by solvents. J. Am. Chem. Soc. 113:1991;4776-4782.
31. Kollman P. Free energy calculations: applications to chemical and biochemical phenomena. Chem. Rev. 93:1993;2395-2417.
32. Jain A.N., Murcko M.A. Computational methods to predict binding free energy in ligand-receptor complexes. J. Med. Chem. 38:1995;4953-4967.